CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Trex Wind-Down Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Trex Wind-Down Inc
3 Mountainview Road, Suite 100
Phone: (917) 697-3130p:917 697-3130 WARREN, NJ  07059  United States Fax: (845) 818-3588f:845 818-3588
This company's Plan of Liquidation went into effect on 5/9/2024
This company ceased filing statements with the SEC on 5/9/2024.
This entity represents the bankrupt estate of the former businesses (assets) of Timber Pharmaceuticals, Inc that were not sold to LEO Pharma A/S and LEO Spiny Merger Sub, Inc. on 1/22/2024
This company is no longer actively traded on any major stock exchange.
Business Summary
Trex Wind-Down, Inc., formerly Timber Pharmaceuticals, Inc., has filed a voluntary petition under Chapter 11 of the United States Bankruptcy Code and is winding down its business. The Company has no operation nor generates any revenue.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
6/30/202312/31/2022YesYesYes--

Industries
SIC Code Description
8731 Commercial physical and biological research

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Executive Vice President AlanMendelsohn 61 1/22/2024 2/4/2021
Chief Restructuring Officer Jeffrey T.Varsalone 51 11/14/2023 11/14/2023
Lead Independent Director Edward J.Sitar 62 5/18/2020 5/18/2020
3 additional Officers and Directors records available in full report.

Business Names
Business Name
BioPharmX, Inc.
Timber Pharmaceuticals LLC
Timber Pharmaceuticals, Inc.
Timer Pharmaceuticals Australia Pty Ltd.

General Information
Number of Employees: 9 (As of 12/31/2022)
Outstanding Shares: 3,432,735 (As of 9/7/2023)
Shareholders: 64
Stock Exchange: OTC
Federal Tax Id: 593843182
Fax Number: (845) 818-3588


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, November 16, 2024